Pediatrix Medical (MD) Net Cash Flow (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Net Cash Flow data on file, last reported at -$169.5 million in Q1 2026.

• Quarterly Net Cash Flow fell 30.75% year-over-year to -$169.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.4 million (up 2.37% YoY) and the FY2025 annual result came in at $145.3 million, down 13.18% from the prior year.
• Net Cash Flow fell to -$169.5 million in Q1 2026 per MD's latest filing, from $35.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $127.9 million in Q4 2024 and bottomed at -$372.7 million in Q1 2022.
• The 5-year median for Net Cash Flow is $3.3 million (2023), against an average of -$10.1 million.
• The widest annual swing landed in 2023, when Net Cash Flow jumped 4405.1%; it then sank 1804.29% in 2024.
• Tracing MD's Net Cash Flow over 5 years: stood at $1.2 million in 2022, then jumped by 4405.1% to $52.1 million in 2023, then soared by 145.6% to $127.9 million in 2024, then plunged by 72.49% to $35.2 million in 2025, then plunged by 581.67% to -$169.5 million in 2026.
• Per Business Quant, the three latest MD Net Cash Flow figures stand at -$169.5 million (Q1 2026), $35.2 million (Q4 2025), and $115.3 million (Q3 2025).

Peer Comparison